BlackRock Health Sciences Trust (BME) - Cash Flow Conversion Efficiency
Based on the latest financial reports, BlackRock Health Sciences Trust (BME) has a cash flow conversion efficiency ratio of -0.017x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-9.45 Million) by net assets ($568.30 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See BlackRock Health Sciences Trust (BME) liquidity interval to measure how many days the company can operate on defensive assets alone.
BlackRock Health Sciences Trust - Cash Flow Conversion Efficiency Trend (2006–2025)
This chart illustrates how BlackRock Health Sciences Trust's cash flow conversion efficiency has evolved over time, based on yearly financial data.
BlackRock Health Sciences Trust Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of BlackRock Health Sciences Trust ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Beijing Bewinner Communications Co Ltd
SHE:002148
|
-0.005x |
|
Temple & Webster Group Ltd
AU:TPW
|
0.227x |
|
Mahindra Holidays & Resorts India Limited
NSE:MHRIL
|
0.349x |
|
Jiangsu Phoenix Property Investment Co Ltd
SHG:600716
|
0.015x |
|
ODDITY Tech Ltd. Class A Ordinary Shares
NASDAQ:ODD
|
-0.023x |
|
BlackRock MIT II
NYSE:BLE
|
-0.063x |
|
SNTEnergy Co Ltd
KO:100840
|
-0.034x |
|
Fulgent Genetics Inc
NASDAQ:FLGT
|
0.007x |
Annual Cash Flow Conversion Efficiency for BlackRock Health Sciences Trust (2006–2025)
The table below shows the annual cash flow conversion efficiency of BlackRock Health Sciences Trust from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see BME market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $568.30 Million | $-4.35 Million | -0.008x | -108.98% |
| 2024-12-31 | $768.57 Million | $65.52 Million | 0.085x | +56.59% |
| 2023-12-31 | $588.14 Million | $32.02 Million | 0.054x | +3838.40% |
| 2022-12-31 | $600.20 Million | $-874.04K | -0.001x | +95.77% |
| 2021-12-31 | $625.77 Million | $-21.56 Million | -0.034x | +2.82% |
| 2020-12-31 | $545.94 Million | $-19.35 Million | -0.035x | -311.19% |
| 2019-12-31 | $1.64 Billion | $-14.10 Million | -0.009x | -248.27% |
| 2018-12-31 | $352.67 Million | $2.05 Million | 0.006x | +264.94% |
| 2017-12-31 | $331.86 Million | $-1.17 Million | -0.004x | -147.50% |
| 2016-12-31 | $270.69 Million | $2.01 Million | 0.007x | +72.61% |
| 2015-12-31 | $297.53 Million | $1.28 Million | 0.004x | -98.87% |
| 2014-12-31 | $303.10 Million | $115.30 Million | 0.380x | +485.01% |
| 2013-12-31 | $270.16 Million | $17.57 Million | 0.065x | -13.63% |
| 2012-12-31 | $218.38 Million | $16.44 Million | 0.075x | +138.74% |
| 2008-12-31 | $179.64 Million | $-34.91 Million | -0.194x | -222.24% |
| 2007-12-31 | $230.28 Million | $36.61 Million | 0.159x | +34.62% |
| 2006-12-31 | $208.15 Million | $24.58 Million | 0.118x | -- |
About BlackRock Health Sciences Trust
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or d… Read more